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Abstract
Background: The development of collections of quantitatively characterized standard biological parts should facilitate the
engineering of increasingly complex and novel biological systems. The existing enzymatic and fluorescent reporters that are
used to characterize biological part functions exhibit strengths and limitations. Combining both enzymatic and fluorescence
activities within a single reporter protein would provide a useful tool for biological part characterization.
Methodology/Principal Findings: Here, we describe the construction and quantitative characterization of Gemini, a fusion
between the b-galactosidase (b-gal) a-fragment and the N-terminus of full-length green fluorescent protein (GFP). We show
that Gemini exhibits functional b-gal activity, which we assay with plates and fluorometry, and functional GFP activity, which
we assay with fluorometry and microscopy. We show that the protein fusion increases the sensitivity of b-gal activity and
decreases the sensitivity of GFP.
Conclusions/Significance: Gemini is therefore a bifunctional reporter with a wider dynamic range than the b-gal a-fragment
or GFP alone. Gemini enables the characterization of gene expression, screening assays via enzymatic activity, and
quantitative single-cell microscopy or FACS via fluorescence activity. The analytical flexibility afforded by Gemini will likely
increase the efficiency of research, particularly for screening and characterization of libraries of standard biological parts.
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Introduction
The number of standard biological parts available to researchers
within the synthetic biology community has grown considerably in
recent years. For example, the Registry of Standard Biological
Parts has expanded from under 50 parts in 2003 to over 3000
parts by 2009 [1]. However, many existing parts have not been
quantitatively characterized [2]. As a result, it is difficult to
accurately predict the behavior of a biological system composed of
such parts. Thus, current engineering practice typically requires
months of testing and tuning before the hoped-for system functions
as desired [3–4]. The inability to select parts based upon their
characterized behavior, or to predict how parts will function
together, may help to explain why the complexity of systems
assembled by synthetic biologists may have reached a plateau [5].
If true, then developing improved collections of well-characterized
standard biological parts would support the more efficient
engineering of increasingly complex and novel biological systems.
Quantitative part characterization seems central to the
engineering of biological systems for several reasons. In general,
part characterization aids the development of mathematical
models that help engineers to simulate the behavior of many
component biological systems prior to physical testing [6]. More
specifically, quantitative transfer functions that characterize the
relationship between input and output signals help engineers to
determine whether the output of one part is compatible, or might
be made compatible, with the input of another [7–8]. Additionally,
engineers can choose characterized parts based upon other
quantitative criteria, such as material and energy resource loads
on a host cell, thereby further reducing the chance that a system
might fail to behave as expected.
Genetically encoded reporter proteins are important and widely
used tools for quantification of promoter activity, translational
efficiency, and protein localization, trafficking, and stability. Many
standard biological parts utilize or depend upon these biochemical
functions [5]. Thus, reporter proteins are widely used for screening
the activity and quantifying the dynamic behavior of standard
biological parts [9–10]. Going forward, the synthetic biology
community would benefit from next generation reporters that
improve upon at least four features common to most reporters.
First, reporters should function in chassis commonly used by
synthetic biologists. Second, reporters should exhibit wide
dynamic range, meaning their activity should be quantifiable
when they are either weakly or strongly expressed. Third, the
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7569dynamic range of reporters should be characterized across a range
of commonly used expression levels, and should be correlated with
measurement reference standards if available. Fourth, reporters
should enable analytical flexibility, ranging from high-throughput
screening to quantitative single cell assays.
The enzymatic and fluorescent reporter proteins currently used
to characterize biological parts have strengths and limitations. For
example, enzymatic reporters, such as b-galactosidase (b-gal),
react with an externally supplied substrate and yield a detectable
product. b-gal has been very effective for high-throughput
screening assays, such as yeast two-hybrid protein interaction
mapping [11], for at least two reasons. First, b-gal exhibits high
sensitivity because even a small amount of enzyme can, over time,
catalytically process many substrate molecules to produce a
detectable signal. Second, colorimetric detection of b-gal activity
with the naked eye using convenient and inexpensive plate assays
is possible. However, the utility of b-gal is also limited. Some b-gal
assays cannot be performed in live cells because substrate
penetration is lethal [12]. Also, while suitable for population-
average measurements, b-gal cannot be easily used for high-
throughput quantification within single cells.
As a second example, fluorescent reporters, such as the green
fluorescent protein (GFP), contain a chromophore intrinsic to the
protein that emits a detectable fluorescent signal after excitation by
light of specific wavelengths [13–14]. Because fluorescent reporters
do not require an exogenous chemical substrate, they can be used
for protein localization studies in live cells and for quantification of
gene expression using time-lapse fluorescence microscopy. In
addition, fluorimetry enables population-averaged measurements
of expression strength, and fluorescence-activated cell sorting
enables high-throughput quantification of expression strength
across single cells. However, the utility of GFP is limited, in that
each molecule provides only one chromophore that will photo-
bleach over time. As a result, GFP is difficult to detect when
weakly expressed, particularly in media or cells having high
autofluorescence [14].
With their intrinsic strengths and limitations in mind, neither
GFP nor b-gal might be individually best suited to meet the
abovementioned needs of the synthetic biology community. While
the parallel, independent assembly of test constructs using both
GFP and b-gal is reasonable for some small-scale studies, such
duplication of effort becomes impractical as the number of parts to
be characterized increases [15]. However, bifunctional reporters
that combined the enzymatic activity of b-gal and fluorescence
activity of GFP, or equivalent, may be well suited for such work:
bifunctional reporters may enable the detection of weak reporter
expression while also supporting screening assays via enzymatic
activity; at the same time, bifunctional reporters may enable time-
lapse fluorescence microscopy or FACS, thereby supporting
measurement of population heterogeneity via fluorescence; finally,
the analytical flexibility afforded by bifunctional reporters might
be useful for characterizing component libraries or many
component sets of biological parts.
With these benefits in mind, we found two examples of
bifunctional reporters that were previously developed for specific
research projects. One bifunctional reporter, which is designed for
use in CHO cells, loach, and chicken embryos, combines full
length LacZ and GFP coding sequences that are optimized for
expression in humans [16]. A second bifunctional reporter is a
fusion between a C. elegens heat shock protein, GFP, and full-length
LacZ [12]. In this work, we describe the development and
quantitative characterization of an improved bifunctional reporter
that is optimized for use in microbes, and that is designed to
support the characterization of many standard biological parts.
Results
We engineered Gemini, a fusion protein encoding both the
enzymatic activity of b-gal and the fluorescence activity of GFP.
We designed a fusion reporter, rather than a polycistronic
reporter, because we hypothesized that the physical coupling of
GFP and b-gal would allow engineers to make more comparable
fluorescent and enzymatic measurements than with independent
GFP and b-gal proteins. Gemini incorporates the b-gal a-fragment
rather than the full-length LacZ coding sequence; the b-gal a-
fragment is able to reconstitute functional b-gal activity via
complementation with the b-gal omega-fragment, which must be
pre-expressed within the cell [17]. We chose to use the b-gal a-
fragment because it is encoded by only 180 base pairs, significantly
less than the 3,075 base pair coding sequence of full-length LacZ.
Due to its reduced coding sequence length, the a-fragment is
easier to clone than full length LacZ. We assembled Gemini by
fusing two BioBrick parts, the b-gal a-fragment (BBa_E0038) and
GFP (BBa_E0043), resulting in a standardized bifunctional
reporter that can be connected to other BioBrick parts via
BioBrick assembly standard #10 [18].
Bifunctional reporter design
We built and tested two different bifunctional reporter designs
(Figure S1). In the first design, the N-terminus of the b-gal a-
fragment (BBa_E0038) is fused directly to the C-terminus of full-
length GFP (BBa_E0043). In the second design, the N-terminus of
full-length GFP is fused to the C-terminus of the b-gal a-fragment
via a linker (Figure 1b). Initial experiments using the first design
yielded functional enzymatic activity, but poor fluorescence
activity (not shown). Initial experiments with the second design
yielded marked fluorescence and enzymatic activity. We named
the second design Gemini and studied it further.
Gemini exhibits functional b-gal and GFP activity
We first confirmed that Gemini encodes functional fluorescence
and enzymatic activities using microscopy and X-gal plates,
respectively. We wanted to fairly compare the fluorescence and
enzymatic activities of Gemini to the individual activities of GFP
and the b-gal a-fragment alone across a range of commonly used
expression levels. To do this, we placed the coding sequences for
each of the three reporters under the control of the same
expression cassettes and vector backbones. Specifically, we placed
all three reporters under the control of a medium strength RBS
(BBa_B0032) and four different promoters of variable strength (in
order of decreasing strength BBa_J23119, 101, 106, 115) on a low-
copy vector (BBa_PSB4A5).
Thus, we built four promoter variants for each reporter: Gemini
(Figure 1C), the b-gal a-fragment alone (Figure S2a), and GFP
alone (Figure S2b). The four promoters were chosen for two
reasons. First, the four promoters are commonly used standard
BioBrick parts. Second, the four promoters span a wide range of
transcriptional activity (Methods).
To test enzymatic activity we grew cells containing promoter
variants for Gemini, GFP, and the b–gal a-fragment on a plate
containing X-gal and IPTG. The plate-based experiments
indicated that the enzymatic activity of Gemini is stronger than
that of b-gal a-fragment alone (Figure 2a). To test fluorescence
activity, we grew cells containing Gemini, GFP, and a-fragment
expression constructs with promoter J23101 in supplemented M9
media at 37uC. We sampled an aliquot in mid-exponential growth
phase for microscopy measurements, which indicated that the
fluorescence activity of Gemini is weaker than that of GFP alone
(Figure 2b).
Genetic Bifunctional Reporter
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Next, we more carefully measured the fluorescence activity of
Gemini relative to GFP alone. We used a Wallac Victor 3
fluorimeter to measure absorbance (Figure S3) and fluorescence
(Figure S4) during a period of log phase growth (Methods). For
GFP promoter variants, we measured fluorescence activity as the
change in GFP molecules per cell per unit time (Figure S5a). For
Gemini promoter variants, we report the fluorescence activity as the
change in molecules of GFP equivalent per cell per unit time
(Figure S5b). We use molecules of GFP equivalent for two reasons.
First, it allows direct comparison with the activity measured for
GFP alone. Second, we do not have a calibration curve that allows
us to calculate molecules of Gemini from arbitrary fluorescence
data. We averaged fluorescence activity for each promoter variant
across thirty minutes of mid-log phase growth for both GFP and
Gemini (highlighted regions in Figure S5). We report fluorescence
activities with error bars that represent the standard deviation of
the averaged activity measurements (Figure 3a).
We measured the enzymatic activity of Gemini relative to b-gal a-
f r a g m e n ta l o n e( F i g u r eS 6 ) .W eu s e daf l u o r o g e n i cs u b s t r a t ef o rt h eb-
galactosidase enzyme to quantify enzymatic activity in a Wallac
Victor 3 fluorimeter (Methods). For the b-gal a-fragment and Gemini
v a r i a n t s ,w ef i tt h ef l u o r e s c e n c ed a t aw i t hal i n e a rr e g r e s s i o n .F r o m
this regression, we determined the enzymatic activity as the change in
arbitrary fluorescence with respect to time (Figure S7 and Figure S8).
We calculated the average enzymatic activity for b-gal and Gemini
across the three replicates for each promoter variant (Figure 3b). We
report enzymatic activities with error bars that represent the standard
deviation of the averaged activity measurements.
We measured the relative activity of each promoter via the
fluorescence activity of GFP alone and Gemini, and via the
enzymatic activity of the b-gal a-fragment alone and Gemini.W e
used promoter J23101 as a reference standard for all relative
promoter measurements by dividing each measured activity
(Figure 3) by the activity of promoter J23101 for the same
reporter (Methods). We report relative promoter units (RPUs) with
error bars that represent the standard deviation of the relative
activity measurements (Figure 4).
Discussion
Design, construction, and characterization of Gemini,a
bifunctional reporter
We describe the construction and quantitative characterization
of Gemini, a fusion of the b-galactosidase (b-gal) a-fragment to the
N-terminus of full-length green fluorescent protein (GFP) that is
designed to support biological part characterization in microbes.
We demonstrate that Gemini exhibits functional b-gal activity,
which we assay with plates or fluorimetry, and GFP activity, which
we assay with fluorimetry or microscopy. We show that
complementation with the a-fragment fused to the N-terminus
of full-length GFP is successful, and that Gemini exhibits more
sensitive enzymatic activity than the b-gal a-fragment alone. We
show that RPU measurements obtained via the fluorescence
activity of Gemini are reasonably consistent with RPU measure-
ments obtained via the fluorescence activity of GFP. We provide a
calibration curve that allows engineers to relate RPU measure-
ments obtained via the fluorescence activity of Gemini with RPU
measurements obtained via enzymatic activity of Gemini.
Figure 1. Function, design, and expected use of Gemini, a bifunctional reporter of gene expression. A) A PoPS input signal, the number
of arriving polymerases per second, drives expression of Gemini. B) Gemini (BBa_E0051) is a fusion reporter composed of both full-length GFP
(BBa_E0043) and the b-gal a-fragment (BBa_E0038). Full-length GFP is fused with a 19 amino acid linker containing a six Histidine tag and
predominantly Glycine and Serine residues to the b-gal a-fragment. C) For characterization of its enzymatic and fluorescence activities across a range
of input PoPS, we placed Gemini under the control of a medium strength RBS (BBa_B0032) and four different promoters of variable strength (in order
of decreasing strength BBa_J23119, 101, 106, 115) on a low-copy vector (BBa_PSB4A5).
doi:10.1371/journal.pone.0007569.g001
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The enzymatic activity of Gemini is more sensitive than the activity of
the b-gal a-fragment alone and the fluorescence activity of Gemini is less
sensitive than the activity of GFP alone. This observation may be
explained by the relative stabilities of GFP and the b-gal a-fragment
alone. GFP is a relatively stable reporter; for example, the reported in
vivo half-life of GFP is ,26 hours in cultured mouse cells [19]. The b-
gal a-fragment is known to be a relatively unstable reporter; for
example, the reported enzymatic activity of the a-fragment is ,25%
that of full-length b-galactosidase [20]. With these points in mind, the
a-fragment may be stabilized by its fusion to GFP, explaining the
greater sensitivity of the b-gal a-fragment in the context of Gemini
relative to the b-gal a-fragment alone. Conversely, GFP may be
relatively destabilized by fusion to the a-fragment. Regardless of the
mechanism, Gemini exhibits a wider dynamic range than either GFP or
the a-fragment alone. Because it is more sensitive, the enzymatic
activity of Gemini can be used to measure the activity of promoters that
cannot be easily detected with the b-gal a-fragment alone (for example,
Figure 2a, promoter J23115). Because the fluorescence activity of
Gemini is weaker than that of GFP alone, Gemini may be used to
measure stronger promoter activity than GFP alone; under the control
of a strong promoter, GFP alone may saturate whereas the weaker
fluorescence activity of Gemini may still be quantifiable (not shown).
RPU measurements obtained via Gemini
Calculating the activity of a promoter that gives rise to a
measured reporter protein synthesis rate requires a mathematical
model. The parameter values within the model are sensitive to the
experimental conditions, which often change from lab to lab and
are generally difficult to measure. Thus, the transcriptional activity
calculated for the same promoter often differs across laboratories
[2]. Yet even if the parameter values governing reporter synthesis
rate under a specific set of experimental conditions are unknown,
the values may not change significantly between different cultures
measured simultaneously within the same laboratory. The reporter
synthesis rate calculated for a culture containing an uncharacter-
ized promoter can be compared to the synthesis rate calculated for
a culture containing a standard reference promoter grown in
parallel. Ideally, the resulting ratio captures only the relative
transcriptional activity between the uncharacterized promoter and
the reference promoter, since all relevant parameters, except the
promoter itself, are consistent between the two experiments. With
this in mind, relative promoter units (RPUs) were developed to
improve consistency in promoter activity measurements across
laboratories and conditions. Using such as approach, a common
reference promoter (J23101), and GFP, one study reduced the
reported variability in measurements of promoter activity across
laboratories by 50% [2].
Ideally, the RPU framework could be extended to reporter
proteins besides GFP, so that different laboratories could make
consistent RPU measurements with arbitrary reporters, and so
that the synthetic biology community would only have to agree
upon a common reference promoter. Clearly, parameter values
such as maturation and degradation rates differ between reporter
proteins. For example, there is a marked difference between the
Figure 2. Gemini encodes both functional enzymatic and fluorescence activities. We wanted to fairly compare the fluorescence and
enzymatic activities of Gemini to the individual activities of GFP and the b-gal a-fragment alone. To do this, we placed the coding sequences for GFP
and the b-gal a-fragment under the control of the same expression cassettes as Gemini. Specifically, we placed all three reporters under the control of
a medium strength RBS (BBa_B0032) and four different promoters of variable strength (in order of decreasing strength BBa_J23119, 101, 106, 115) on
a low-copy vector (BBa_PSB4A5). Thus, we built four promoter variants for each reporter. A) To test enzymatic activity, we grew cells containing
promoter variants for Gemini, GFP, and the b–gal a-fragment on a plate containing X-gal and IPTG. The plate-based experiments indicated that the
enzymatic activity of Gemini is stronger than that of the b-gal a-fragment alone. B) To test fluorescence activity, we grew cells containing Gemini, GFP,
and a-fragment expression constructs with promoter J23101 in supplemented M9 media. An aliquot was sampled in mid-exponential growth phase
for microscopy measurements. Microscopy measurements indicated that the fluorescence activity of Gemini is functional and weaker than that of GFP
alone.
doi:10.1371/journal.pone.0007569.g002
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are expressed under the control of the same strong promoters
J23119 and J23101, ceteris paribus (Figure 3a). Even if the
parameter values that quantify the expression, maturation, and
degradation rates of a reporter protein, such as Gemini, are
unknown, the values may not change significantly when the
reporter is placed under the control of different promoters. If these
parameters do not change with respect to promoter activity, then
RPU measurements obtained via Gemini should capture the
relative transcriptional activity between the test and reference
promoter, and should be consistent with measurements obtained
via GFP alone.
RPU measurements obtained via the fluorescence activity of
GFP are consistent within the bounds of measurement error with
RPU measurements obtained via the fluorescence activity of
Gemini (Figure 4a). This suggests that parameter values such as
maturation and degradation rates for Gemini are reasonably
insensitive to changes in promoter activity. If these parameters
were sensitive to changes in promoter activity, a more significant
divergence between RPU measurements obtained via GFP and
Gemini would be expected. Instead, the results suggest that RPU
measurements obtained via reporters other than GFP can be
consistent with GFP, therefore extending the RPU framework to
fluorescent reporters besides GFP.
However, we found an inconsistency between RPU measure-
ments obtained via the fluorescence and enzymatic activities of
Gemini. Specifically, we observed that at high expression levels the
relative promoter measurements obtained via the fluorescence
activity of Gemini (Figure 4a) diverge from the relative promoter
measurements obtained via the enzymatic activity of Gemini
(Figure 4b). One explanation for this divergence is that the
enzymatic activity of Gemini may saturate if the quantity of
expressed Gemini-encoded a-fragment exceeds the amount of
complementing omega-fragment present within cells. Careful
characterization of a functional full-length b-gal GFP fusion
(unpublished results, Kortemme Lab, UCSF) would help to
consider this model.
Finally, any future efforts to improve Gemini should note that
Western blot experiments on cell extracts revealed two bands for
Gemini (Figure S9). One band was near the size expected for Gemini
(,35.7 kDa) and the other appeared to be a cleavage product
(,30.7 kDa). Further Western blot experiments using a protocol
optimized to improve size discrimination across this mass range
yielded a band for the cleavage product at ,30.1 kDa (Figure
S9b). Given that the predicted mass for GFP plus the linker is
,28.7 kDa, we expect that Gemini is being cut within the b-gal a-
fragment (that is, ,1.4–2.0 kDa beyond the linker). Thus, for
Gemini and perhaps for any full-length b-gal GFP fusion,
proteolytic cleavage may decouple the 1:1 stoichiometric coupling
of the two reporter epitopes. For now, and until perfect 1:1
stoichiometric coupling can be demonstrated, RPU measurements
obtained via the enzymatic activity of Gemini can be related to
RPU measurements obtained via the fluorescence activity of
Gemini using calibration curves (such as Figure S10).
Figure 3. Gemini encodes stronger enzymatic activity than the b-gal a-fragment and weaker fluorescence activity than GFP. We
wanted to quantitatively compare the fluorescence and enzymatic activities of Gemini to the individual activities of GFP and the b-gal a-fragment
alone. A) We used a fluorimeter to measure arbitrary fluorescence (Figure S4) during a period of log phase growth for cells containing GFP and
Gemini promoter variants. We averaged the fluorescence activity for each promoter variant (shown on the x-axis) across thirty minutes of mid-log
phase growth for both GFP and Gemini (highlighted regions in Figure S5). We report the fluorescence activities for GFP and Gemini with error bars
that represent the standard deviation of the averaged activity measurements. B) We also measured the enzymatic activity of Gemini relative to the b-
gal a-fragment alone. We used a fluorogenic substrate for the b-galactosidase enzyme to quantify enzymatic activity in a Wallac Victor 3 fluorimeter
(Methods). For the b-gal a-fragment and Gemini variants, we fit the fluorescence data with a linear regression. From this regression, we determined
the enzymatic activity as the change in arbitrary fluorescence with respect to time. We calculated the average enzymatic activity for the b-gal and a-
fragment Gemini across the three replicates for each promoter variant. We report enzymatic activities with error bars that represent the standard
deviation of the averaged activity measurements.
doi:10.1371/journal.pone.0007569.g003
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Construction of reporter variants
We assembled Gemini via overlap PCR. We made constructs
containing GFP (BBa_E0043) and LacZ-a (BBa_E0038) via
separate PCR reactions. We performed one PCR reaction using
LacZ-a as template with the primers one through three (below).
We performed a second PCR using GFP as template with primers
four through six (below). We gel purified each PCR product. We
used a third PCR reaction to stitch the two products together using
primers one and six to form the bifunctional reporter, Gemini
(BBa_E0051). We Qiaquick gel purified the PCR product,
digested it EcoRI and PstI restriction endonucleases, and cloned
the digested PCR product into BioBrick vector, pSB1A3.
(1) tgccacctgacgtctaagaa
(2) gatgttcgctgccgccgccttcgctgccgcccgcgcgccattcgccattc
(3) cgctgccatgatgatgatgatgatgttcgctgccgccgccttc
(4) gaacatcatcatcatcatcatggcagcgaacgtaaaggagaagaacttttcac,
(5) gaaggcggcggcagcgaacatcatcatcatcatcatggcag
(6) attaccgcctttgagtgagc
We added RBS B0032 to Gemini via PCR. We performed PCR
of the bifunctional reporter plasmid template using primers 6 and
7. We Qiaquick gel purified this PCR product, digested it with
XbaI and PstI, and then performed a Qiagen ERC cleanup on the
cut PCR product. We cut the destination vector pSB4A5 with
EcoRI/PstI and then performed gel purification on the cut vector.
(7) gaattctctagagtcacacaggaaagtactagatgaccatgattacggattcac
We ligated different promoters to the digested PCR products
containing the B0032 RBS and Gemini. We chose standard BioBrick
promoters J23119, J23101, J23106, and J23115, because these
promoters span a wide range of transcriptional activity and are
commonly used by synthetic biologists. We synthesized both strands
of each promoter variant as oligos containing an EcoRI overhang in
front and SpeI overhang in the back. We normalized these oligos to
50 mM. For each oligo, we added 1 mlo ft h eo l i g ot oa1 0ml reaction
with 1 ml 10x T4 DNA ligase buffer, 8 mlw a t e r ,a n d0 . 5mlT 4P N K
tophosphorylatethe59ends.AfterPNKtreatment,wemixedthetwo
complementary oligos together, heated them to 80uC, and allowed
them to cool slowly. We ligated these promoters with the cut pSB4A5
vector and PCR products to form each of the promoter variants.
We wanted to fairly compare the fluorescence and enzymatic
activities of Gemini to the individual activities of GFP and the b-gal
a-fragment alone. To do this, we placed the coding sequences for
GFP (BBa_E0043) and LacZ-a (BBa_E0038) under the control of
the same expression cassettes, and on the same vector backbone,
as Gemini. We used the Bricklayer assembly service provided by
Ginkgo BioWorks to build the four GFP and four LacZ-a
promoter variants, resulting in three sets of expression constructs:
Gemini (Figure 1C), the b-gal a-fragment alone (Figure S2a), and
GFP alone (Figure S2b).
Measurement of fluorescence and enzymatic activity
We transformed the twelve expression constructs into E. coli
TOP10 cells (Invitrogen). We grew the transformed E. coli on LB
agar plates containing ampicilin (1:1000 dilution) antibiotic. After
overnight incubation, we inoculated 5 ml test tubes containing LB
medium and ampicilin (1:1000 dilution) with a single colony for
each expression construct. After overnight incubation, we purified
plasmid DNA for each expression construct using a mini-prep kit
(Qiagen) and sequenced all expression constructs.
We used supplemented M9 medium (M9 salts, 1 mM thiamine
hydrochloride, 0.2% casamino acids, 0.1 M MgSO4, 0.5 M
Figure 4. RPU measurements via Gemini are reasonably consistent with RPU measurements via GFP and the b-gal a-fragment. We
measured the relative activity of each promoter via A) the fluorescence activity of GFP alone and Gemini, and B) via the enzymatic activity of the b-gal
a-fragment alone and Gemini. We made RPU measurements by dividing the activity for each promoter (Figure 3) by the activity of promoter J23101
for the same reporter. We report promoter activities in relative promoter units (RPU) with error bars that represent the standard deviation of the
relative activity measurements.
doi:10.1371/journal.pone.0007569.g004
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ampicilin (1:1000 dilution) antibiotic for measurements of
fluorescence activity for all expression constructs. We inoculated
three test tubes containing 5 ml of sterile supplemented M9
medium with a single colony for each of the twelve reporter
constructs. As a result, we grew three replicates for each of the
twelve expression constructs. We grew the 36 cultures for
approximately 18 hrs at 37uC. We then diluted each culture by
a factor of 1:100 into 5 ml of fresh media. We grew the diluted
cultures for approximately five hours under the previous
conditions.
After five hours, we measured the optical density of a 200 ml
aliquot from each culture on a Wallac Victor3 multi-well
fluorimeter (Perkin Elmer). We converted the optical density
measurements from the fluorimeter to OD600 measurements
using a standard calibration curve (not shown). We diluted the 36
cultures to the same optical density in 5 ml of fresh media and
grew them for one hour at 37uC. We transferred a 200 ml aliquot
from each of the 36 cultures into a well on a flat-bottomed 96 well
plate (Nunc). We incubated the plate in a Wallac Victor3 multi-
well fluorimeter at 37uC and assayed the samples with an
automatically repeating protocol of absorbance measurements
(600 nm absorbance filter, 0.1 second counting time), fluorescence
measurements (485 nm excitation filter, 525 nm emission filter,
0.1 second measurement time), and shaking (20 second interval
between measurements with 2.0 mm shaking diameter and double
orbital shaking type).
We determined background absorbance by measuring wells
containing only media, and background fluorescence by measur-
ing the fluorescence of TOP10 cells without a GFP expressing
vector. After background subtraction, we converted time-series
fluorescence (Figure S4) and absorbance (Figure S3) measurements
to GFP molecules per well and CFUs per well respectively, using
standard calibration curves previously reported for the fluorimeter
used in these experiments [1]. We calculated GFP synthesis rates
(GFP molecules per cell per second) for all expression constructs
containing GFP (Figure S5a). We also calculated GFP synthesis
rates (molecules of GFP equivalent per cell per second) for all
expression constructs containing Gemini (Figure S5b). We used
molecules of GFP equivalent were used for two reasons. First, it
allows direct comparison with the activity measured for GFP
alone. Second, we do not have a standard calibration curve that
allows us to calculate molecules of Gemini from arbitrary
fluorescence data. We averaged the synthesis rates across thirty
minutes of mid-log phase growth for both GFP and Gemini
promoter variants (highlighted regions in Figure S5). We report
the resulting fluorescence activities for GFP and Gemini with error
bars that represent the standard deviation of the averaged activity
measurements (Figure 3a).
After measurement of fluorescence activities, we measured
enzymatic activity for each reporter in the three sets of expression
constructs. We used E. coli TOP10 cells that contain the LacZ
omega fragment necessary for LacZ-a complementation. We
induced the LacZ omega fragment by growing cells in supple-
mented M9 medium with IPTG inducer (1:1000 dilution). We
used the flourogenic substrate 4-methylumbelliferyl-D-galactopyr-
anoside (Sigma Aldrich #M1633), otherwise known as MUG, to
measure b-gal activity. We dissolved the MUG in DMSO at a
concentration of 2 mg/ml and used the resulting solution as a 10x
stock. After measurement of fluorescence activities, we transferred
a sample from each culture (10 ml) to a new well containing 20 ml
of the MUG stock solution and PBS 170 ml for a total final volume
of 200 ml. We were careful to ensure that cell density was
consistent between the cultures prior to measuring b-gal activity
(Figure S6). We measured fluorescence produced by reaction
between b-gal and the MUG substrate using an automatically
repeating protocol of measurements (355 nm excitation filter,
460 nm emission filter) on the Wallac Victor3 multi-well
fluorimeter (Figure S7). We fit a linear regression to the time-
series fluorescence data to measure the enzymatic activity for the
b-gal a-fragment and Gemini expression constructs (Figure S8).
We measured the relative activity of each promoter via the
fluorescence activity of GFP alone and Gemini, and via the
enzymatic activity of the b-gal a-fragment alone and Gemini.W e
performed relative measurements using the method reported by
Kelly et al [1]: we divided the measured activity (Figure 3) for each
promoter by the activity of promoter J23101. We did this for the
fluorescence activity of GFP alone, the fluorescence activity of
Gemini, the enzymatic activity of the b-gal a-fragment alone, and
the enzymatic activity of activity of Gemini. We report promoter
activities in relative promoter units (RPU) with error bars that
represent the standard deviation of the relative activity measure-
ments (Figure 4).
Supporting Information
Figure S1 Two designs for the bifunctional reporter of gene
expression. A) In the first design, we fused the N-terminus of the b-
gal a-fragment (BBa_E0038) to the C-terminus of full-length GFP
(BBa_E0043). B) In the second design, we fused the N-terminus of
full-length GFP to the C-terminus of the b-gal a-fragment with a
linker.
Found at: doi:10.1371/journal.pone.0007569.s001 (5.67 MB TIF)
Figure S2 Constructs used to benchmark the activity of Gemini.
We wanted to fairly compare the fluorescence and enzymatic
activities of Gemini to the individual activities of GFP and the b-gal
a-fragment alone. To do this, we placed the coding sequences for
each of the three reporters under the control of the same
expression cassettes and vector backbones. This resulted in three
sets of expression constructs. For each reporter, we built four
promoter variants: Gemini (Figure 1C), A) b-gal a-fragment alone,
and B) GFP alone.
Found at: doi:10.1371/journal.pone.0007569.s002 (1.40 MB TIF)
Figure S3 Absorbance data and growth rates for GFP and
Gemini promoter variants. We measured time-series absorbance for
A) GFP and B) Gemini expression constructs on a fluorimeter and
converted to OD600 using a calibration curve (Methods). We
calculated growth rates for cells containing C) GFP and D) Gemini
expression constructs for two reasons. First, growth rates were used
to confirm that Gemini has no detrimental impact on cell growth
relative to the stand-alone reporters. Two, growth rates were used
to determine a regime of steady-state cell growth for subsequent
measurements of reporter activity. Error bars represent the
standard deviation of the averaged measurements for three
replicates for each promoter variant.
Found at: doi:10.1371/journal.pone.0007569.s003 (2.51 MB TIF)
Figure S4 Fluorescence and GFP concentrations for GFP and
Gemini promoter variants. We measured time-series fluorescence
for A) GFP and B) Gemini expression constructs with a fluorimeter
(Methods). We calculated GFP concentrations for C) GFP D)
Gemini promoter variants (Methods). Error bars represent the
standard deviation of the averaged measurements for three
replicates for each promoter variant.
Found at: doi:10.1371/journal.pone.0007569.s004 (1.57 MB TIF)
Figure S5 Fluorescence activity for GFP and Gemini promoter
variants. We calculated fluorescence activities for A) GFP and B)
Gemini promoter variants using the fluorescence data shown in
Genetic Bifunctional Reporter
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averaged fluorescence activities for thirty minutes of log phase
growth, during which time was little fluctuation in the cell growth
rate (Figure S3 c and d). Error bars represent the standard
deviation of the averaged measurements for three replicates for
each promoter variant.
Found at: doi:10.1371/journal.pone.0007569.s005 (2.02 MB TIF)
Figure S6 Optical density of cultures prior to enzymatic activity
assay. We assayed enzymatic activities for promoter variants of the
b-gal a-fragment and Gemini at a consistent starting cell density.
Found at: doi:10.1371/journal.pone.0007569.s006 (1.81 MB TIF)
Figure S7 MUG fluorescence for b-gal a-fragment and Gemini
promoter variants. We measured time-series fluorescence pro-
duced by reaction between the MUG substrate and b-gal for A)
the b-gal a-fragment and B) Gemini expression constructs with a
fluorimeter (Methods). Error bars represent the standard deviation
of the averaged measurements for three replicates for each
promoter variant.
Found at: doi:10.1371/journal.pone.0007569.s007 (1.99 MB TIF)
Figure S8 MUG fluorescence measured across replicates for
each promoter variant of the b-gal a-fragment and Gemini.W e
measured MUG fluorescence for three replicates for each
promoter variant of the b-gal a-fragment and Gemini. We fit a
linear regression to the data for each replicate, and used the
regression to calculate the enzymatic activity. We averaged
enzymatic activities for the three replicates for each promoter
variant of the b-gal a-fragment and Gemini (Figure 3b). We report
enzymatic activities with error bars that represent the standard
deviation of the averaged activity measurements.
Found at: doi:10.1371/journal.pone.0007569.s008 (1.94 MB TIF)
Figure S9 Western blot for Gemini and GFP. A) We performed
Western blot on cells containing Gemini, GFP, and the b-gal a-
fragment expression constructs with promoter J23119 using anti-
GFP antibody. Thus, the b-gal a-fragment is the negative control
shown. Western blot reveals two bands for Gemini. One band is
near the size expected for Gemini, and the other band appears to be
a cleavage product of Gemini. B) We optimized Western blot
protocol to achieve better discrimination between the sizes of the
Gemini bands.
Found at: doi:10.1371/journal.pone.0007569.s009 (1.23 MB TIF)
Figure S10 Calibration curve for Gemini. RPU measurements
obtained via the enzymatic activity of Gemini can be related to
RPU measurements obtained via fluorescence activity of Gemini
using a calibration curve.
Found at: doi:10.1371/journal.pone.0007569.s010 (0.83 MB TIF)
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